| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |